Characteristics of traveler with Middle East respiratory syndrome, China, 2015

Emerging Infectious Diseases

Volumn 21, Issue 12, 2015, Pages 2278-2280

  Da Guan, Wen ^a   Mok, Chris Ka Pun ^b   Chen, Zi Lin ^c   Feng, Li Qiang ^d   Li, Zheng Tu ^a   Huang, Ji Cheng ^e   Ke, Chang Wen ^f   Deng, Xilong ^g   Ling, Yun ^c   Wu, Shi Guan ^a   Niu, Xue Feng ^a   Perera, Ranawaka A ^b   Xu, Yuan Da ^a   Zhao, Jincun ^a   Zhang, Lin Qi ^h   Li, Yi Min ^a   Chen, Rong Chang ^a   Peiris, Malik ^b   Chen, Ling ^a,d   Zhong, Nan Shan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^d GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^e Guangdong Inspection and Quarantine Technology Center   (China)

^f GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^g Guangzhou Eighth Municipal People's Hospital   (China)

^h Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; CHEMOKINE RECEPTOR CXCR3; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSELTAMIVIR; PEGINTERFERON ALPHA2A; RIBAVIRIN; THYMOSIN ALPHA1; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANEMIA; CASE REPORT; CORONAVIRUS INFECTION; EMPORIATRICS; HUMAN; LETTER; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VIRUS CHARACTERIZATION; VIRUS LOAD; CHINA; CORONAVIRUS INFECTIONS; FEMALE; PATHOGENICITY; PATHOLOGY; TRANSMISSION; TRAVEL;

CHINA; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; TRAVEL;

EID: 84947433966     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2112.151232     Document Type: Letter

References (10)

1. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015;20:pii: 21163.
2. Park HY, Lee EJ, Ryu YW, Kim Y, Kim H, Lee H, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015; 20:pii: 21169.
3. World Health Organization. Middle East respiratory syndrome coronaviruses (MERS-CoV) [cited 2015 Sep 5]. http://www.who.int/emergencies/mers-cov/en/
4. Wu J, Yi L, Zou L, Zhong H, Liang L, Song T, et al. Imported case of MERS-CoV infection identified in China, May 2015: detection and lesson learned. Euro Surveill. 2015;20:pii:21158.
5. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis. 2014;210:1590–4. http://dx.doi.org/10.1093/infdis/jiu292
6. El Sabaawy D, El-Haggar S, El-Bahrawy, Waked I, El-Said H. A comparative study of variants of pegylated interferon alpha in treatment of chronic HCV patients. APMIS. 2015;123:482–9. http://dx.doi.org/10.1111/apm.12377
7. Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS ONE. 2014;9:e88716. http://dx.doi.org/10.1371/journal.pone.0088716
8. Scheuplein VA, Seifried J, Malczyk AH, Miller L, Höcker L, Vergara-Alert J, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol. 2015;89:3859–69. http://dx.doi.org/10.1128/JVI.03607-14
9. Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014;59:118–28. http://dx.doi.org/10.1007/s12026-014-8534-z
10. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18:pii=20574.